ANNUAL REPORT

Company

Tonix Pharmaceuticals Holding Corp.

Filed

March 18, 2019

Period of Report

December 31, 2018

Accession Number

0001387131-19-001980

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →